Lndip-Trio Tablet
By Lndip-Trio
Rx
10 Tablet in a Strip

Composition
Telmisartan(40mg) + Cilnidipine(10mg) + Chlorthalidone(12.5mg)

Manufacturer - Fusion Healthcare Pvt Ltd
Fusion House, Plot No. 22, H.No 8-2-350/B, Road No. 3, Banjara Hills, Hyderabad, Telangana-500034

Expires on or after
February, 2026
About Lndip-Trio Tablet
Lndip-Trio Tablet is a combination medication used to treat high blood pressure, also known as hypertension, in adults. This tablet is recommended when a single medication alone is not effective in controlling blood pressure. By lowering high blood pressure levels, Lndip-Trio Tablet plays a crucial role in reducing the risk of future heart attacks and strokes in patients.
The tablet contains three important drugs that work together to achieve the desired effect. These drugs include Chlorthalidone, which acts as a diuretic or water pill, Cilnidipine, a calcium channel blocker, and Telmisartan, an angiotensin II receptor blocker. Each of these components has a specific function in helping to manage hypertension effectively.
Chlorthalidone helps in removing excess water and certain salts like sodium and potassium from the blood, leading to a reduction in the fluid volume circulating through the blood vessels. On the other hand, Cilnidipine relaxes the muscle cells in artery walls, which in turn widens the arteries, improves blood flow, and enhances oxygen supply to the heart. Telmisartan works by blocking a hormone called angiotensin II, which is responsible for narrowing blood vessels, thereby helping to lower blood pressure.
It is essential to take Lndip-Trio Tablet with food as directed by your doctor. The dosage will depend on your specific condition and how you respond to the medication. It is crucial to take the tablet at the same time each day and continue the course until your doctor advises otherwise. Remember, high blood pressure often does not cause noticeable symptoms, so consistent usage of the medication is key to reducing the risk of heart-related issues.
While using Lndip-Trio Tablet, it is common to experience side effects such as ankle swelling, headache, dizziness, tiredness, and taste changes. If any of these side effects persist or worsen, it is important to consult your doctor. Additionally, ensure you drink plenty of fluids to counteract potential side effects like muscle weakness, dry mouth, and extreme thirst.
Before starting Lndip-Trio Tablet, inform your doctor about any pre-existing liver or kidney conditions. Pregnant or breastfeeding women should seek medical advice before taking this medication. It is crucial to disclose all other medications you may be taking, especially those related to high blood pressure or heart conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood sugar is recommended to ensure the medication is working effectively.
Benefits
Lndip-Trio Tablet, specifically Macsart CC 12.5 Tablet 10's, offers several benefits for individuals dealing with hypertension (high blood pressure). The tablet works by relaxing the blood vessels in the body, making it easier for blood to flow smoothly. Additionally, it helps in removing excess water from the body, leading to increased urine output. By doing so, Lndip-Trio Tablet effectively lowers blood pressure and decreases the likelihood of experiencing a stroke, heart attack, or kidney issues in the future.
This medication not only addresses the current symptoms but also plays a crucial role in long-term health management. While the benefits may not be immediately felt, consistent and regular use of Macsart CC 12.5 Tablet 10's as prescribed is essential for optimal effectiveness. Even if you start feeling better, it's important to continue taking the medication as recommended to maintain overall well-being and prevent potential complications associated with high blood pressure. Chlorthalidone, Cilnidipine, and Telmisartan, the active ingredients in Lndip-Trio Tablet, work together harmoniously to provide these therapeutic benefits. Chlorthalidone acts as a diuretic, aiding in the removal of excess water and certain salts from the blood, thus improving blood circulation. Meanwhile, Cilnidipine and Telmisartan contribute by relaxing and widening blood vessels, further reducing blood pressure and lowering the risk of cardiovascular events.
Overall, Lndip-Trio Tablet, particularly Macsart CC 12.5 Tablet 10's, not only helps in managing high blood pressure but also offers significant protective benefits against serious health complications related to hypertension. By following your healthcare provider's instructions and incorporating this medication into your daily routine, you can work towards maintaining a healthy blood pressure level and safeguarding your cardiovascular health in the long run.
How to use the Lndip-Trio Tablet
To use Lndip-Trio Tablet properly, it is important to follow the advice of your doctor. Take the tablet in the dose and duration recommended by your physician. Remember to swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet. It is recommended to take Lndip-Trio Tablet with food to prevent any stomach upset. Your doctor will determine the right dosage and duration based on factors such as your age, body weight, and the specific condition being treated. Make sure to strictly adhere to the instructions provided to ensure the effectiveness of the medication.
Uses of Lndip-Trio Tablet
Lndip-Trio Tablet is effectively used to treat essential hypertension, commonly known as high blood pressure, in adults. By effectively managing high blood pressure, this medication also helps in reducing the risk of both stroke and heart attack. This tablet is beneficial for individuals looking to control their blood pressure levels and lower the chances of serious cardiovascular events.
What conditions Lndip-Trio Tablet treats?
High blood pressure, also known as hypertension, is a chronic condition where the force of blood pumping through the body is too high. This can lead to hardened arteries, reducing blood and oxygen flow to the heart. As a result, complications such as chest pain, heart attack, brain damage (stroke), and kidney failure can occur. Diagnosis of high blood pressure can be done using a blood pressure monitor. Normal blood pressure readings fall between 90/60 mmHg and 120/80 mmHg, while levels of 140/90 mmHg or higher indicate high blood pressure.
Should you consult a doctor?
If you experience decreased levels of potassium and sodium, increased levels of calcium and urea, gout, or uric acid calculi, it is advisable to avoid using Lndip-Trio Tablet. Additionally, individuals with Addison's disease should not use this medication. Before starting Lndip-Trio Tablet, inform your doctor if you have diabetes, low blood pressure, or show signs of high potassium in the body such as muscle weakness, numbness in limbs, irregular heartbeat, or fast heartbeat. Also, seek medical advice if you are experiencing symptoms of raised aldosterone levels, like extreme thirst and muscle spasms. Consulting a healthcare professional before taking Lndip-Trio Tablet is crucial to ensure the medication is safe for your specific health condition.
Side effects of Lndip-Trio Tablet
When taking Lndip-Trio Tablet, some people may experience side effects while their body gets used to the medicine. These side effects can include ankle swelling, headache, dizziness, tiredness, palpitations, sleepiness, increased blood uric acid, glucose intolerance, taste changes, flushing (sense of warmth in the face, ears, neck, and trunk), upset stomach, and altered blood lipid levels. Other possible side effects may include low blood pressure, stomach upset, tachycardia, loss of appetite, change in blood glucose levels, gastric irritation, signs of urinary tract infection like bladder pain and frequent urination, signs of upper respiratory tract infection such as sore throat and common cold symptoms, anemia, insomnia, depression, fainting, vertigo, slow heart rate, cough, shortness of breath, abdominal discomfort, bloating, diarrhea, vomiting, itching, increased sweating, drug rash, back pain, muscle cramps and pain, chest pain, weakness, low blood pressure, signs of high eosinophil count like fever and night sweats, signs of low platelet count such as easy bleeding, severe allergic reactions, allergy symptoms like rash and swelling, low blood sugar in diabetic patients, anxiety, impaired vision, fast heartbeat, dry mouth or impaired taste, eczema, joint pain, flu-like symptoms, and severe joint pain with stiffness and slurred speech. In rare cases, serious side effects such as sepsis and angioedema may occur, and it's important to seek immediate medical help if you experience these. If you have concerns about side effects, or if they persist, consult your doctor for guidance.
Safety advice

liver
When using Lndip-Trio Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dose of the tablet in such cases, so it is advised to consult with your doctor before taking it. Please note that the use of Lndip-Trio Tablet is not recommended for patients with severe liver disease. Prior medical guidance is essential for individuals with liver issues to ensure the safe use of this medication.

kidney
Caution should be taken when using Lndip-Trio Tablet in patients with severe kidney disease. Dose adjustment may be necessary, and it is advisable to consult a doctor. The use of Lndip-Trio Tablet is not recommended in such patients.

alcohol
It is not safe to drink alcohol while taking Lndip-Trio Tablet.

driving
When taking Lndip-Trio Tablet, be cautious as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Lndip-Trio Tablet should not be used during pregnancy because it can harm the developing baby. Only in serious cases where the benefits outweigh the risks, a doctor may consider prescribing it. Always consult your doctor before taking this medication during pregnancy.

breastfeeding
It is better to consult your doctor before using Lndip-Trio Tablet during breastfeeding.
Age above 75(Geriatrics)
Age below 6 months(Pediatrics)
Consumption warning before consuming Lndip-Trio Tablet
Before consuming Macsart CC 12.5 Tablet 10's, it is important to note the following precautions. Firstly, if you have any allergies to this medication or other drugs, inform your physician. This tablet is not suitable for individuals under 18 years old. Pregnant or breastfeeding women should avoid using Macsart CC 12.5 Tablet 10's without consulting a doctor. Prior to undergoing surgery or receiving anesthesia, notify your doctor about your Macsart CC 12.5 Tablet 10's intake. Additionally, if you have conditions such as low sodium or potassium levels, gout, kidney stones, Addison’s disease, high blood calcium, or severe liver/kidney issues, avoid taking this medication. Driving should only be done when fully alert as this tablet could cause dizziness or fatigue. Furthermore, it is advised to refrain from alcohol consumption while using Macsart CC 12.5 Tablet 10's as it could heighten the risk of low blood pressure.
What if you forgot to take Lndip-Trio Tablet?
If you happen to miss a dose of Lndip-Trio Tablet, it's important to take it as soon as you remember. But if your next scheduled dose is almost due, it's better to skip the missed dose and continue with your regular dosing schedule. Avoid taking a double dose to make up for the missed one. It's crucial to stick to the prescribed dosing regimen for your treatment to be effective.
What happens if you take overdose of Lndip-Trio Tablet?
In case of accidentally taking an excessive amount of Lndip-Trio Tablet, it is crucial to seek immediate medical attention from your doctor or visit the nearest hospital. Overdosing on this medication can heighten the chances of experiencing various side effects. Some common signs and symptoms of an overdose may include low blood pressure, dizziness, nausea, increased levels of creatinine in the blood, sudden kidney failure, electrolyte imbalances leading to irregular heartbeats, and muscle stiffness. If you suspect an overdose or witness any of these symptoms, do not delay seeking medical help to prevent any further complications.
Related lab tests
Related Lab Tests:
When taking Macsart CC Tablets, it is important to monitor your kidney function and electrolyte levels regularly through specific lab tests. The kidney function test helps in assessing how well your kidneys are working by measuring waste products in your blood. This test can include measuring creatinine and blood urea nitrogen (BUN) levels. Additionally, a serum electrolyte test is crucial to check the balance of essential minerals such as sodium, potassium, chloride, and bicarbonate in your blood. These tests are vital in ensuring the safe and effective use of Macsart CC Tablets and monitoring any potential side effects on your kidneys and electrolyte levels. It is recommended to discuss with your healthcare provider for the appropriate frequency and timing of these lab tests while on Macsart CC Tablets.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹171
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024